DMAA Screen, Serum/Plasma Test (9229SP)

DMAA Screen, Serum/Plasma Test (9229SP)

Analysis Code 9229SP 
Test Name DMAA Screen, Serum/Plasma 
Test Includes DMAA 
Compound Synonym(s) 1,3-dimethylamylamine; Methylhexaneamine 
Purpose Drug of Abuse Monitoring; This test is New York State approved. 
Category Stimulant 
Method(s) High Performance Liquid
Chromatography/Time of
Flight-Mass Spectrometry (LC/TOF-MS) 
Specimen Requirements 3 mL Serum or Plasma 
Transport Temperature Refrigerated 
Specimen Container Plastic container (preservative-free) 
Special Handling Serum: Collect sample in Red top tube
Plasma: Collect sample in Lavender top tube (EDTA) or Pink top tube.
Promptly centrifuge and separate Plasma into a plastic screw capped vial using approved guidelines. 
Light Protection Required Not Required 
Stability Room Temperature: 30 day(s)
Refrigerated: 30 day(s)
Frozen (-20 °C): 12 month(s) 
*Rejection Criteria Polymer gel separation tube (SST or PST). 
Day(s) Test Set-up / TAT [LC/TOF-MS] Tuesday / 5 days 
Suggested CPT Code 80307 
**Minimum Volume 1.1 mL 
Reflex Testing
(when required, addl' fee may apply)
52375SP - DMAA Confirmation, Serum/Plasma 
Test Summary Sheet Generate  

You are viewing DMAA Screen, Serum/Plasma Test (9229SP)
*Rejection criteria pertain to clinical specimen submissions only.
**Stated minimum volume allows for a single analysis. Repeat analysis will not be performed.


A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9